Prediction of mortality from 12-lead electrocardiogram voltage data using a deep neural network.

Journal: Nature medicine
PMID:

Abstract

The electrocardiogram (ECG) is a widely used medical test, consisting of voltage versus time traces collected from surface recordings over the heart. Here we hypothesized that a deep neural network (DNN) can predict an important future clinical event, 1-year all-cause mortality, from ECG voltage-time traces. By using ECGs collected over a 34-year period in a large regional health system, we trained a DNN with 1,169,662 12-lead resting ECGs obtained from 253,397 patients, in which 99,371 events occurred. The model achieved an area under the curve (AUC) of 0.88 on a held-out test set of 168,914 patients, in which 14,207 events occurred. Even within the large subset of patients (n = 45,285) with ECGs interpreted as 'normal' by a physician, the performance of the model in predicting 1-year mortality remained high (AUC = 0.85). A blinded survey of cardiologists demonstrated that many of the discriminating features of these normal ECGs were not apparent to expert reviewers. Finally, a Cox proportional-hazard model revealed a hazard ratio of 9.5 (P < 0.005) for the two predicted groups (dead versus alive 1 year after ECG) over a 25-year follow-up period. These results show that deep learning can add substantial prognostic information to the interpretation of 12-lead resting ECGs, even in cases that are interpreted as normal by physicians.

Authors

  • Sushravya Raghunath
    Department of Translational Data Science and Informatics, Geisinger, Danville, PA, USA.
  • Alvaro E Ulloa Cerna
    Department of Translational Data Science and Informatics, Geisinger, Danville, PA, USA.
  • Linyuan Jing
    Department of Imaging Science and Innovation, Geisinger, Danville, Pennsylvania.
  • David P vanMaanen
    Department of Translational Data Science and Informatics, Geisinger, Danville, PA, USA.
  • Joshua Stough
    Department of Translational Data Science and Informatics, Geisinger, Danville, PA, USA.
  • Dustin N Hartzel
    Phenomic Analytics and Clinical Data Core, Geisinger, Danville, PA, USA.
  • Joseph B Leader
    Phenomic Analytics and Clinical Data Core, Geisinger, Danville, PA, USA.
  • H Lester Kirchner
    Department of Population Health Sciences, Geisinger, Danville, PA, USA.
  • Martin C Stumpe
    Google Health, Palo Alto, CA USA.
  • Ashraf Hafez
    Tempus Labs, Inc., Chicago, IL, USA.
  • Arun Nemani
    Tempus Labs, Inc., Chicago, IL, USA.
  • Tanner Carbonati
    Tempus Labs, Inc., Chicago, IL, USA.
  • Kipp W Johnson
  • Katelyn Young
    Department of Internal Medicine, Geisinger, Danville, PA, USA.
  • Christopher W Good
    Department of Cardiology, Geisinger, Danville, Pennsylvania.
  • John M Pfeifer
    Heart and Vascular Center, Evangelical Hospital, Lewisburg, PA, USA.
  • Aalpen A Patel
    Department of Radiology, Geisinger, Danville, PA, USA.
  • Brian P Delisle
    Department of Physiology and Cardiovascular Research Center, University of Kentucky, Lexington, KY, USA.
  • Amro Alsaid
    Heart Institute, Geisinger, Danville, PA, USA.
  • Dominik Beer
    Heart Institute, Geisinger, Danville, PA, USA.
  • Christopher M Haggerty
    IT Data Science, NewYork-Presbyterian Hospital, New York, New York, USA.
  • Brandon K Fornwalt
    Department of Imaging Science and Innovation, Geisinger, Danville, Pennsylvania; Department of Biomedical Engineering, University of Kentucky, Lexington, Kentucky; Department of Radiology, Geisinger, Danville, Pennsylvania. Electronic address: bkf@gatech.edu.